Company: NMP
Filing Date: 2025-06-27
Form Type: S-1/A
Source: 0001213900-25-059138
Chunk: 118

Company: NMP Acquisition Corp.
Filing Date: 2025-06-27
Form: S-1/A
Chunk 118
---
, you and the other public shareholders will incur an immediate and substantial dilution of approximately 99.60% (or $9.96 per share, assuming no exercise of the underwriters’ over -allotmentoption), the difference between the pro forma net tangible book value per share of $0.04 and the deemed offering price of $10.00 per unit. This dilution would increase to the extent that the anti -dilutionprovisions of the Class B ordinary shares result in the issuance of Class A ordinary shares on a greater than one -to -onebasis upon conversion of the Class B ordinary shares at the time of our initial business combination and would become exacerbated to the extent that public shareholders seek redemptions from the trust. In addition, because of the anti -dilutionprotection in the founder shares, any equity or equity -linkedsecurities issued or deemed issued in connection with our initial business combination would be disproportionately dilutive to our Class A ordinary shares. We may amend the terms of the rights in a way that may be adverse to holders with the approval by the holders of a majority of the then outstanding rights. Our rights will be issued in registered form under a rights agreement between Continental Stock Transfer & Trust Company, as rights agent, and us. The rights agreement provides that the terms of the rights may be amended without the consent of any holder to cure any ambiguity or correct any defective provision. The rights agreement requires the approval by the holders of a majority of the then outstanding rights in order to make any change that adversely affects the interests of the registered holders. 74 Our rights and founder shares may have an adverse effect on the market price of our Class A ordinary shares and make it more difficult to effectuate our initial business combination. We will be issuing rights to receive 2,000,000 of our Class A ordinary shares (or up to 2,300,000 of our Class A ordinary shares if the underwriters’ over -allotmentoption is exercised in full) at the consummation of our initial business combination, as part of the units offered by this prospectus. Simultaneously with the closing of this offering, we will be issuing private placement rights to receive an aggregate of 34,000 (or 35,500 if the underwriters’ over -allotmentoption is exercised in full) of our Class A ordinary shares at the consummation of our initial business combination as part of the private placement units in a private placement. Prior to this offering, our